表紙
市場調查報告書

全球動物用疫苗佐劑市場:成長,趨勢,預測

Veterinary Vaccine Adjuvants Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 907030
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球動物用疫苗佐劑市場:成長,趨勢,預測 Veterinary Vaccine Adjuvants Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年06月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球動物用疫苗佐劑市場相關調查,提供市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 推動市場的要素
  • 阻礙市場的要素
  • 波特的五力分析

第5章 市場區隔

  • 各類型
    • 明礬和鈣鹽
    • 油乳劑佐劑
    • 微脂體,Archaeosome
    • 奈米粒子和微粒子
    • 其他
  • 各用途
    • 研究
    • 商用
  • 各給藥途徑
    • 口服
    • 皮下
    • 肌肉內
    • 其他
  • 各動物類型
    • 家畜
    • 寵物
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭環境

  • 企業簡介
    • Bioveta as
    • Brenntag Biosector AS
    • Novavax
    • Phibro Animal Health Corporation
    • SEPPIC
    • SPI Pharma
    • Zoetis

第7章 市場機會與未來趨勢

目錄
Product Code: 64174

Market Overview

The Veterinary Vaccine Adjuvant market is anticipated to grow with a CAGR of around 6.4%, during the forecast period (2019-2024).

The growth of this market is owing to several factors, such as the rising use of adjuvants in the vaccine, an increase in livestock population and their associated diseases, and high incidence of infectious zoonotic diseases. For instance, according to the data published by the World Health Organization (WHO) 411 million livestock keepers belong to the rural poor population of 911 million people, from South Asia and the Sub-Saharan African region. Such close contact with animals is the major reason associated with the transfer of infectious zoonotic diseases. In addition, as per the Centers for Disease Control and Prevention (CDC), zoonotic diseases are very common and about three out of every four new or emerging infectious diseases in people are spread from animals, and more than six out of every 10 known infectious diseases in people are spread from animals. So, for the treatment of the aforementioned infectious zoonotic diseases, various types of vaccines are used. Thus, the growing burden of zoonotic diseases is among the major growth factor for the veterinary vaccine adjuvant market.

Scope of the Report

Vaccine adjuvants are substances that help to enhance the immune response of vaccine. The adjuvants can be broadly classified into two types, the first one is vaccine delivery systems and the second one is immunostimulatory adjuvants.

Key Market Trends

Alum and Calcium Salts is Expected to Hold the Largest Share in the Market Segmentation by Type

Aluminum-based adjuvants have been used most commonly for vaccine preparations for more than 80 years. They include aluminum hydroxide and phosphate adjuvants, as well as calcium phosphate adjuvants. In addition, the safety of these adjuvants is excellent, and there are very fewer side effects. But there are some allergic reactions and granulomas occasionally in a few cases. And moreover, the recent developments, such as the use of aluminum oxyhydroxide nanoparticles in the formulation of vaccine adjuvants, are more effective in the prevention of infectious diseases and treatment of various diseases.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the rising adoption of companion animals, increasing pet healthcare insurance, and improved veterinary healthcare infrastructure. In the North America region, the United States holds the largest market share. And with the rising trends of zoonotic diseases in the United States, the associated use of the veterinary vaccine is also increasing. Hence, it is expected to propel the growth of the veterinary vaccine adjuvants market over the forecast period.

Competitive Landscape

The Veterinary Vaccine Adjuvant market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising prevalence of infectious diseases in the animals, few other smaller players are expected to enter into the market in the coming years. Some of the major players of the market are SEPPIC, SPI Pharma, Brenntag Biosector A/S, Bioveta AS, and Zoetis are among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Use of Adjuvants in Vaccine
    • 4.2.2 Increase in Livestock Population and their Associated Diseases
    • 4.2.3 High Incidence of Infectious Zoonotic Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Toxicity and Side Effects of Adjuvants
    • 4.3.2 Stringent Regulatory Environment and Time-consuming Approvals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Alum and Calcium Salts
    • 5.1.2 Oil Emulsion Adjuvants
    • 5.1.3 Liposomes and Archaeosomes
    • 5.1.4 Nanoparticles and Microparticles
    • 5.1.5 Other Types
  • 5.2 By Application
    • 5.2.1 Research Application
    • 5.2.2 Commercial Application
  • 5.3 By Route of Administration
    • 5.3.1 Oral
    • 5.3.2 Subcutaneous
    • 5.3.3 Intramuscular
    • 5.3.4 Other Routes of Administration
  • 5.4 By Animal Type
    • 5.4.1 Livestock
    • 5.4.2 Companion Animal
    • 5.4.3 Other Animal Types
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 US
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 UK
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bioveta as
    • 6.1.2 Brenntag Biosector AS
    • 6.1.3 Novavax
    • 6.1.4 Phibro Animal Health Corporation
    • 6.1.5 SEPPIC
    • 6.1.6 SPI Pharma
    • 6.1.7 Zoetis

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top